Reuters exclusively reports WHO-led program aims to buy antiviral COVID-19 pills for $10

Business & FinanceHealth

Reuters exclusively reported that a World Health Organization-led program to ensure poorer countries get fair access to COVID-19 vaccines, tests and treatments aims to secure antiviral drugs for patients with mild symptoms for as little as $10 per course. Merck & Co’s experimental pill molnupiravir is likely to be one of the drugs, and other drugs to treat mild patients are being developed. According to a draft document seen by Reuters, which outlines the goals of the Access to COVID-19 Tools Accelerator (ACT-A) until September next year, the program wants to deliver about 1 billion COVID-19 tests to poorer nations and procure drugs to treat up to 120 million patients globally, out of about 200 million new cases it estimates in the next 12 months.

Article Tags

Topics of Interest: Business & FinanceHealth

Type: Reuters Best

Sectors: Pharmaceuticals & Healthcare

Regions: Global

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Major Global Story

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *